Dr. Lohith Reddy has come up with multiple Immuno-Radiotherapy combinations that support efficient management of multiple cancer types.
Dr. Lohith heads the precision oncology initiative at HCG, dealing with Radiomics and Radio-genomics to facilitate personalised cancer therapy.
Dr. Lohith is a recipient of various prestigious awards such as the “Research Award” from ESMO and “Award for Research” from the Society of Neuro-oncology, Scottsdale, USA.
He is a member of the European Society of Medical Oncology.
He has authored and co-authored publications in several indexed and non-indexed international journals.
He has also presented his papers at various conferences worldwide.
He was an invited faculty at Harvard Business School, Boston, USA
Area of Expertise: Dr. Lohith’s expertise lies in the treatment of cancers in the head & neck region, breast, prostate and brain. Dr. Lohith heads the precision oncology initiative at HCG and is well-versed in the fields of radiomics and radio-genomics, which focus on personalised cancer therapy. He is trained in high-precision radiotherapy techniques, such as 3D CRT, IMRT, IGRT, SART, SBRT, proton therapy, carbon ion therapy and brachytherapy. Dr. Lohith has handled over 1650 cancers so far.